2024 Q2 Form 10-Q Financial Statement

#000149315224019838 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $1.181M $187.0K $303.0K
YoY Change 75.22% -38.28% 15050.0%
Cost Of Revenue $667.0K $410.0K $550.0K
YoY Change -14.16% -25.45% 90.97%
Gross Profit $514.0K -$223.0K -$247.0K
YoY Change -599.03% -9.72% -13.64%
Gross Profit Margin 43.52% -119.25% -81.52%
Selling, General & Admin $1.470M $1.574M $1.134M
YoY Change -11.5% 38.8% -25.83%
% of Gross Profit 285.99%
Research & Development $1.408M $1.567M $1.398M
YoY Change 3.91% 12.09% 46.54%
% of Gross Profit 273.93%
Depreciation & Amortization $31.00K $33.00K $155.0K
YoY Change -16.22% -78.71% 210.0%
% of Gross Profit 6.03%
Operating Expenses $2.878M $3.141M $2.532M
YoY Change -4.58% 24.05% 2.3%
Operating Profit -$2.364M -$3.364M -$2.779M
YoY Change -24.21% 21.05% 0.65%
Interest Expense $202.0K $86.00K
YoY Change 134.88% -418.52%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$3.162M -$2.686M
YoY Change 17.72% -3.66%
Income Tax
% Of Pretax Income
Net Earnings -$2.182M -$3.162M -$2.686M
YoY Change -24.13% 17.72% -3.66%
Net Earnings / Revenue -184.76% -1690.91% -886.47%
Basic Earnings Per Share -$0.21 $0.30 -$0.37
Diluted Earnings Per Share -$0.21 $0.30 -$0.37
COMMON SHARES
Basic Shares Outstanding 10.45M shares 10.45M shares 10.43M shares
Diluted Shares Outstanding 10.45M shares 10.45K shares 7.276K shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.59M $24.59M
YoY Change -36.6% 27.28%
Cash & Equivalents $13.24M $7.362M $9.583M
Short-Term Investments $8.228M $15.01M
Other Short-Term Assets $657.0K $562.0K $564.0K
YoY Change -1.65% -0.35% 35.58%
Inventory $439.0K $604.0K $693.0K
Prepaid Expenses
Receivables $758.0K $123.0K $61.00K
Other Receivables $0.00 $0.00
Total Short-Term Assets $15.41M $17.19M $25.91M
YoY Change -34.73% -33.65% 29.93%
LONG-TERM ASSETS
Property, Plant & Equipment $443.0K $466.0K $508.0K
YoY Change -13.65% -8.27% -58.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $96.00K $96.00K $268.0K
YoY Change -63.36% -64.18% -31.28%
Total Long-Term Assets $3.168M $3.352M $2.557M
YoY Change 12.98% 31.09% -22.11%
TOTAL ASSETS
Total Short-Term Assets $15.41M $17.19M $25.91M
Total Long-Term Assets $3.168M $3.352M $2.557M
Total Assets $18.57M $20.54M $28.46M
YoY Change -29.67% -27.83% 22.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $292.0K $399.0K $365.0K
YoY Change -62.27% 9.32% 60.79%
Accrued Expenses $1.371M $943.0K
YoY Change 45.39% 12.4%
Deferred Revenue $611.0K $557.0K $1.304M
YoY Change -35.95% -57.29%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.643M $2.670M $2.620M
YoY Change -11.4% 1.91% 11.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.468M
YoY Change -24.73%
Total Long-Term Liabilities $2.505M $2.726M $2.468M
YoY Change -4.75% 10.45% -24.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.643M $2.670M $2.620M
Total Long-Term Liabilities $2.505M $2.726M $2.468M
Total Liabilities $5.148M $5.396M $5.088M
YoY Change -8.28% 6.05% -9.48%
SHAREHOLDERS EQUITY
Retained Earnings -$39.55M -$37.40M -$27.45M
YoY Change 30.53% 36.26%
Common Stock $52.98M $52.51M $50.82M
YoY Change 3.63% 3.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.43M $15.15M $23.38M
YoY Change
Total Liabilities & Shareholders Equity $18.57M $20.54M $28.46M
YoY Change -29.67% -27.83% 22.57%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$2.182M -$3.162M -$2.686M
YoY Change -24.13% 17.72% -3.66%
Depreciation, Depletion And Amortization $31.00K $33.00K $155.0K
YoY Change -16.22% -78.71% 210.0%
Cash From Operating Activities -$2.093M -$1.230M -$2.474M
YoY Change -19.78% -50.28% 1004.46%
INVESTING ACTIVITIES
Capital Expenditures $8.000K $22.00K $15.00K
YoY Change -80.95% 46.67% -162.5%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$12.00M
YoY Change -100.0%
Cash From Investing Activities $7.992M -$22.00K -$12.02M
YoY Change -325.64% -99.82% 49962.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $13.98M
YoY Change
NET CHANGE
Cash From Operating Activities -$2.093M -$1.230M -$2.474M
Cash From Investing Activities $7.992M -$22.00K -$12.02M
Cash From Financing Activities $13.98M
Net Change In Cash $5.899M -$1.252M -$512.0K
YoY Change -194.92% 144.53%
FREE CASH FLOW
Cash From Operating Activities -$2.093M -$1.230M -$2.474M
Capital Expenditures $8.000K $22.00K $15.00K
Free Cash Flow -$2.101M -$1.252M -$2.489M
YoY Change -20.75% -49.7% 1144.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
usd
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
usd
CY2024Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
usd
CY2024Q1 ODYS Severance Pay Asset And Liability
SeverancePayAssetAndLiability
usd
CY2024Q1 ODYS Withdrawal Short Term Deposits
WithdrawalShortTermDeposits
usd
CY2024Q1 ODYS Payments Investment To Short Term Deposits
PaymentsInvestmentToShortTermDeposits
usd
CY2024Q1 ODYS Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023Q1 ODYS Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations
TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations
usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7362000 usd
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
310000 usd
CY2024Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
8228000 usd
CY2023Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
8096000 usd
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
123000 usd
CY2024Q1 us-gaap Inventory Gross
InventoryGross
604000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
562000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
17189000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
1196000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
466000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1327000 usd
CY2024Q1 ODYS Severance Pay Asset
SeverancePayAsset
267000 usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
96000 usd
CY2024Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
3352000 usd
CY2024Q1 us-gaap Assets
Assets
20541000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
399000 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
557000 usd
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
472000 usd
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
899000 usd
CY2024Q1 ODYS Account Payable Other Current
AccountPayableOtherCurrent
304000 usd
CY2023Q4 ODYS Account Payable Other Current
AccountPayableOtherCurrent
211000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2670000 usd
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1690000 usd
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
779000 usd
CY2024Q1 ODYS Liability For Severance Pay
LiabilityForSeverancePay
257000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28000 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
2726000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
5396000 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10446685 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10446685 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10443768 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10443768 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
10000 usd
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
52504000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37369000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
15145000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20541000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
187000 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
410000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
550000 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
-223000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
-247000 usd
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1567000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1398000 usd
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
234000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
176000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1340000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
958000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3364000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2779000 usd
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
7000 usd
CY2024Q1 ODYS Financing Income Expenses Net
FinancingIncomeExpensesNet
202000 usd
CY2023Q1 ODYS Financing Income Expenses Net
FinancingIncomeExpensesNet
86000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3162000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2686000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.37
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.37
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10445 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10445 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7276 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7276 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
17807000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
500000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3162000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
15145000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11786000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
11786000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
348000 usd
CY2023Q1 ODYS Stock Issued During Period Value Of Shares And Warrants
StockIssuedDuringPeriodValueOfSharesAndWarrants
13927000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2686000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
23375000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
23375000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-3162000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2686000 usd
CY2024Q1 us-gaap Depreciation
Depreciation
33000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
155000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
500000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
348000 usd
CY2023Q1 ODYS Severance Pay Asset And Liability
SeverancePayAssetAndLiability
-54000 usd
CY2024Q1 ODYS Interest And Exchange Differences From Operating Lease Liability
InterestAndExchangeDifferencesFromOperatingLeaseLiability
17000 usd
CY2023Q1 ODYS Interest And Exchange Differences From Operating Lease Liability
InterestAndExchangeDifferencesFromOperatingLeaseLiability
9000 usd
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-21000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4000 usd
CY2024Q1 ODYS Interest Income In Respect Of Deposits
InterestIncomeInRespectOfDeposits
132000 usd
CY2023Q1 ODYS Interest Income In Respect Of Deposits
InterestIncomeInRespectOfDeposits
-42000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1249000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1000 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
100000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
63000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-114000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-48000 usd
CY2024Q1 ODYS Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
109000 usd
CY2023Q1 ODYS Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
44000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
130000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
283000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
112000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
68000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
2000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
50000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-60000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-60000 usd
CY2024Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-75000 usd
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-228000 usd
CY2024Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
353000 usd
CY2023Q1 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-63000 usd
CY2024Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
65000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
182000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1230000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2474000 usd
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15000 usd
CY2023Q1 ODYS Withdrawal Short Term Deposits
WithdrawalShortTermDeposits
3000000 usd
CY2023Q1 ODYS Payments Investment To Short Term Deposits
PaymentsInvestmentToShortTermDeposits
15000000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12015000 usd
CY2023Q1 ODYS Proceeds From Issuance Of Shares And Warrants
ProceedsFromIssuanceOfSharesAndWarrants
13977000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13977000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1252000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-512000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8945000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10099000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-21000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7672000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9583000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
87000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
83000 usd
CY2024Q1 ODYS Termination Of Rightofuse Assets In Exchange For Cancellation Of Operating Lease Obligations
TerminationOfRightofuseAssetsInExchangeForCancellationOfOperatingLeaseObligations
-31000 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_804_eus-gaap--NatureOfOperations_zCmq2h8G4qmb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_82B_zQdzhnEf0Iid">GENERAL</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>a</b>.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Odysight.ai Inc (the “Company”), formerly known as ScoutCam Inc., was incorporated under the laws of the State of Nevada on March 22, 2013.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s wholly owned subsidiary, Odysight.ai Ltd (“Odysight.ai”), formerly known as ScoutCam Ltd., was incorporated in the State of Israel on January 3, 2019, and was merged into the Company on December 31, 2019 in a share exchange transaction, following which the surviving operations of the merged entity were the operations of Odysight.ai. On February 28, 2024, D. VIEW Ltd., a wholly owned subsidiary of the Company, was incorporated in the state of the Israel to act as a local agent for the defense market in Israel.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company, through its subsidiaries, provides image-based platforms. Through the use of its proprietary visualization technology, the Company offers solutions across predictive maintenance and condition-based monitoring markets, in sectors such as energy, automotive and aviation. The Company’s solutions are based on small and highly resilient cameras, specialized AI analysis and supplementary technologies. Some of the Company’s products utilize micro visualization technology in medical devices for minimally invasive medical procedures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ODYSIGHT.AI INC. (Formerly known as ScoutCam Inc.)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – GENERAL </b>(continued):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>b</b>.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since incorporation of Odysight.ai and through March 31, 2024, the Company accumulated a deficit of approximately $<span id="xdx_90F_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20240331_z76N5gmLAaj1" title="Accumulated deficit">37.4</span> million and its activities have been funded mainly by its shareholders. The Company’s management believes the Company’ cash and cash resources will allow the Company to fund its operating plan through at least the next 12 months from the filing date of these Consolidated Financial Statements. However, the Company expects to continue to incur significant research and development and other costs related to its ongoing operations, requiring the Company to obtain additional funding in order to continue its future operations until becoming profitable.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-37400000 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zI1v8sEvgrXf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>c. <span id="xdx_863_zFOCrs1noAn4">Use of estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. The Company evaluates on an ongoing basis its assumptions, including those related to contingencies, deferred taxes, inventory impairment, stock-based compensation, as well as in estimates used in applying the revenue recognition policy. Actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Sublease Income
SubleaseIncome
7000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
151000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
57000 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y10M20D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.06 pure
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
433000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
539000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
421000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
154000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1547000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
296000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1251000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2455069 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.46
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2455069 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.46
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
1245669 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
3.46
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
500000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
348000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
187000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
303000 usd
CY2024Q1 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P7Y
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1196000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1256000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2247000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2322000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1256000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1495000 usd
CY2024Q1 ODYS Contract With Customer Asset Contract Costs
ContractWithCustomerAssetContractCosts
-60000 usd
CY2023 ODYS Contract With Customer Asset Contract Costs
ContractWithCustomerAssetContractCosts
-239000 usd
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1196000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1256000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2322000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3644000 usd
CY2024Q1 ODYS Contract With Customer Liability Revenue Recognized Development Services
ContractWithCustomerLiabilityRevenueRecognizedDevelopmentServices
-75000 usd
CY2023 ODYS Contract With Customer Liability Revenue Recognized Development Services
ContractWithCustomerLiabilityRevenueRecognizedDevelopmentServices
-1322000 usd
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2247000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2322000 usd
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2200000 usd
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
441000 usd
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
445000 usd
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
50000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
34000 usd
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
113000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
25000 usd
CY2024Q1 us-gaap Inventory Net
InventoryNet
604000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
504000 usd
CY2024Q1 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2023Q1 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
29000 usd
CY2024Q1 ODYS Royalties Agreement Description
RoyaltiesAgreementDescription
Pursuant to the agreement with the IIA relating to the program, the Company has to pay royalties of 3% to the IIA up to the amount IIA funding received and the accrued interest repayment of the grant is contingent upon the Company successfully completing its enhancement plans and generating sales from the enhancements preformed.

Files In Submission

Name View Source Status
0001493152-24-019838-index-headers.html Edgar Link pending
0001493152-24-019838-index.html Edgar Link pending
0001493152-24-019838.txt Edgar Link pending
0001493152-24-019838-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
odys-20240331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
odys-20240331_def.xml Edgar Link unprocessable
odys-20240331_lab.xml Edgar Link unprocessable
odys-20240331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
odys-20240331_cal.xml Edgar Link unprocessable